KH-CB19 is a potent and highly specific inhibitor of the CDC2-like kinase isoforms 1 and 4 (CLK1/CLK4).
KH-CB19 showed potent inhibition of CLK1 with an IC50 of 20 nM, and for the pure isomer KH-CB19, almost 100-fold selectivity against the CLK3 isoform. Pretreatment of cells with KH-CB19 or TG003 led to a reduction of the TNF--induced increase in phosphorylation of all analyzed SR proteins compared with TNF--stimulated controls.Treatment of resting cells with 10 M KH-CB19 significantly reduced the basal expression of flTF as well as asHTF.
For research use only. We do not sell to patients.
Name | KH-CB19 |
---|---|
Iupac Chemical Name | KH-CB19 |
Synonyms | KH-CB-19 |
Molecular Formula | C15H13Cl2N3O2 |
Molecular Weight | 338.19 |
InChiKey | |
InChi | |
CAS Number | 1354037-26-5 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | crystalline solid |
---|---|
Purity | 98% |
Storage | 3 years -20ºCpowder |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |